TipRanks
Go Ultimate55% OFF

Cadrenal Therapeutics, Inc. (CVKD) Income Statement

Cadrenal Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Cadrenal Therapeutics, Inc.'s total revenue was $0.00. In Q2, Cadrenal Therapeutics, Inc.'s net income was $-3.32M. See Cadrenal Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Dec 24Dec 23Dec 22
$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ -1.88K$ 0.00$ -1.27K
$ 13.46M$ 10.96M$ 7.63M$ 2.70M
Depreciation and Amortization$ 6.87K$ 1.88K$ 1.98K$ 1.27K
$ -13.23M$ -10.65M$ -8.34M$ -6.61M
$ -13.46M$ -10.96M$ -7.63M$ -2.70M
$ 223.81K$ 309.25K$ -724.24K$ -4.01M
$ -13.24M$ -10.65M$ -8.36M$ -6.71M
$ -13.24M$ -10.65M$ -8.36M$ -6.71M
Per Share Metrics
Basic EPS$ -6.64$ -8.73$ -9.63$ -8.66
Diluted EPS$ -6.64$ -8.73$ -9.63$ -8.66
Weighted Average Shares Outstanding1.99M1.22M868.18K775.64K
Weighted Average Shares Outstanding (Diluted)1.99M1.22M868.18K775.64K

Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

-15M-10M-5M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin